Semax is an experimental drug that was originally developed back in Russia to prevent and treat circulatory disorders. It has also been identified as a “nootropic” or “cognitive enhancer.”

Also known as the Heptapeptide SEMAX (MEHFPGP), it is the analog of ACTH. It has been seen to demonstrate prolonged neuropathic activity.

Historically, it has been used in patients experiencing pathologies connected to brain circulation dysfunction. This has also been suggested in literature because of its effects on carboxypeptidase which may increase physical performance and adaptation capacities in exposure due to high intensity and exercises at high doses.